Clinical Trials Logo

Filter by:
NCT ID: NCT01234974 Withdrawn - Multiple Myeloma Clinical Trials

IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus

Start date: December 2010
Phase: Phase 2
Study type: Interventional

Observe the safety/tolerability and effectiveness in terms of response rate and duration of response of the combination pasireotide + everolimus in the treatment of patients with relapsed/refractory multiple melanoma.

NCT ID: NCT01234285 Withdrawn - Sepsis Clinical Trials

Safety of Heparin in Patients With Septic Shock

Start date: December 2010
Phase: Phase 2
Study type: Interventional

Sepsis is a syndrome comprised of a systemic inflammatory response, signs of tissue hypoperfusion, and organ in the setting of presumed infection. Heparin, in addition to being an anticoagulant, is also a well-known antiinflammatory. The investigators believe that unfractionated heparin has the potential to save the lives of septic patients at a drastically reduced cost. This is a dose escalation study to determine the safety of increasing levels of heparin in this patient population; compare markers of anticoagulation and inflammation between treatment groups; and compare clinical outcomes between groups.

NCT ID: NCT01233674 Withdrawn - Fibrosis Clinical Trials

Examination of Left Atrial Fibrosis Using MRI

Start date: March 2011
Phase:
Study type: Observational

This study evaluates images obtained from a standard clinical cardiac MRI for evidence of fibrosis.

NCT ID: NCT01233661 Withdrawn - Clinical trials for Stable Cardiac Status (i.e. no Hospitalizations or Cardiac Medication Changes Within 3 Months)

Short Atrioventricular Delay Pacing

SAVD
Start date: January 2011
Phase: N/A
Study type: Interventional

We intend to examine the effects of temporary elevation of atrial wall stress by shortening of the atrioventricular delay in patients with dual-chamber pacemakers.

NCT ID: NCT01233479 Withdrawn - Clinical trials for Brain and Central Nervous System Tumors

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Start date: May 2010
Phase: N/A
Study type: Interventional

RATIONALE: Studying samples of blood in the laboratory from patients receiving radiation therapy and chemotherapy may help doctors learn more about the effects of this treatment on cells. It may also help doctors understand how well patients respond to treatment. PURPOSE: This research study is studying biomarkers in blood samples from young patients with newly diagnosed brain tumors undergoing standard radiation therapy and chemotherapy.

NCT ID: NCT01232777 Withdrawn - Clinical trials for Retinopathy of Prematurity

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)

BLOCK-ROP
Start date: June 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a single intravitreal (into the gel of the eye) injection of Avastin 0.625mg or 0.75mg is equivalent (non-inferior) to treatment with standard of care laser in infants with Type I pre-threshold retinopathy of prematurity (ROP) diagnosed at 30-36 weeks gestational age.

NCT ID: NCT01232400 Withdrawn - Clinical trials for Subarachnoid Hemorrhage

Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage

ABASH
Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the clinical effect of esmolol treatment on cardiac function and electrophysiology; to assess the effects of esmolol treatment on serum adrenergic and cardiac biomarkers; to explore the safety of esmolol treatment shortly after subarachnoid hemorrhage (SAH). Patients will be followed for a maximum of 1 month after the index SAH. The primary outcome will be change in systolic function - ejection fraction by Simpson's rule (baseline versus Day 7 +/- 2 after SAH).

NCT ID: NCT01231724 Withdrawn - Allergic Rhinitis Clinical Trials

Topical Allstate and Nasal Allergen Challenge

Start date: November 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to see whether Allstate Nasal Spray when given in the nose is safe and can reduce the signs and symptoms of allergic rhinitis (hayfever).

NCT ID: NCT01231191 Withdrawn - Postoperative Pain Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical Procedures

Cadence
Start date: n/a
Phase: Phase 4
Study type: Interventional

This is a research study to determine if giving acetaminophen intravenously in hte operating room will decrease the number of patients who require additional pain medicine, such as morphine, after surgery in the recovery room.

NCT ID: NCT01230151 Withdrawn - Parkinson's Disease Clinical Trials

Feasibility Study to Evaluate Deep Brain Stimulation (DBS) Settings for the Treatment of Parkinson's Disease

SAGE
Start date: December 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the cognitive performance in patients with advanced Parkinson's disease receiving Deep Brain Stimulation (DBS) with settings predetermined clinically to settings derived from a patient-specific computational model.